BrokerLens

Symbiotec Pharmalab Limited IPO (SYMBIOTEC)

Status
Listed
Security type
Mainboard
Price band
Rs.938 to Rs.988
Final issue price
Rs 988
Issue size
Not disclosed
Bidding opens
24 August 2026
Bidding closes
27 August 2026
Listing date
1 September 2026

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Symbiotec Pharmalab Limited IPO?

The Symbiotec Pharmalab Limited IPO price band is Rs.938 to Rs.988 per share.

When does the Symbiotec Pharmalab Limited IPO open and close?

Bidding opens 24 August 2026 and closes 27 August 2026.

Is the Symbiotec Pharmalab Limited IPO a mainboard or SME issue?

Symbiotec Pharmalab Limited is a mainboard IPO, listing on NSE's main board.

When did the Symbiotec Pharmalab Limited IPO list?

Symbiotec Pharmalab Limited listed on 1 September 2026.

Does this page show the grey market premium (GMP) for Symbiotec Pharmalab Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Symbiotec Pharmalab Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.